Q4 2024 Earnings Call Transcript March 4, 2025 Rigel Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.8, expectations were $0.3. Operator: Greetings, and welcome to Rigel ...
Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET. Company Participants. Ray Furey - Executive Vice President, General Counsel & ...
With defocus contact lenses on the market, research into future myopia management techniques narrow in on defocus spectacles ...
A cluster of deaths linked to a mysterious illness in the Democratic Republic of the Congo could be the result of a poisoning ...
Heart attacks and strokes rise exponentially with age and make a major contribution to increasing healthcare costs and lost productivity. In the UK more than 7 million people are living with ...
Jagged 1-Notch2 signaling and a distinctive progenitor-like gene expression profile. Within the limitations of the PDX system they used, their methods are state-of-the-art, their data are strong and ...
Advances in stem cell biology and immune cell engineering bring diabetes cell therapies closer to reality.